What is Montelukast API?
Montelukast API refers to montelukast as the active pharmaceutical ingredient (API), used in medicines marketed under brand names such as Singulair. Montelukast API is the chemical ingredient manufacturers use to produce finished products (tablets or chewables) for asthma prevention and to help with allergic rhinitis symptoms.
What is it used for in asthma and allergies?
Montelukast is commonly prescribed to:
- Help prevent asthma symptoms (including exercise-induced symptoms) and reduce flare-ups.
- Treat symptoms of seasonal allergic rhinitis (and sometimes related allergic conditions, depending on the product and country).
What does “API” mean for buyers and manufacturers?
If you are searching for “Montelukast api” in a supply or procurement context, it usually means you want:
- The raw active ingredient itself (montelukast) rather than a finished dosage form.
- Documentation typically associated with pharmaceutical-grade supply chains (for example, quality/testing documentation), since APIs are used in regulated manufacturing.
Is there a patent or exclusivity angle for montelukast?
If your goal is to understand intellectual property status around montelukast (or generic/manufacturer supply), DrugPatentWatch.com is one place to check for patent and exclusivity details for specific compounds and jurisdictions: DrugPatentWatch.com - Montelukast.
What’s next—do you mean dosage form, chemistry, or sourcing?
“Montelukast api” can refer to different needs. Tell me which one you mean:
- the medicine information (uses, side effects, dosing),
- the chemical/API details (specifications, grades, sourcing),
- or patents/exclusivity for generic manufacturing.
If you share your country/market and whether you need API for procurement or just general drug info, I can narrow the answer.
Sources
- https://www.drugpatentwatch.com/patent/